Stereotactic Ablative Body Radiotherapy (SABR) has been a great tool for managing low volume metastatic prostate cancer for a few years now. One or two visits to the radiation centre, highly targeted, minimal side-effects. So could it be used to treat the primary prostate cancer itself with similar success? Today we have top SABR experts Dr Alison Tree (Royal Marsden Hospital, London), and Associate Professor Shankar SIva (Peter Mac, Melbourne) in the GU Cast studio, and Dr Gerard Morton on Zoom from Sunnybrook Cancer Centre in Toronto. Alison talks through the most recent update from the PACE-B study and we ask which technology is best for prostate cancer. Full video podcast available on our YouTube channel 

Ver todos los episodios